1. H2AFZ: A Novel Prognostic Marker in Canine Melanoma and a Predictive Marker for Resistance to CDK4/6 Inhibitor Treatment
   Laura Bongiovanni et al, 2021, Frontiers in Veterinary Science CrossRef
2. Design and synthesis of novel 1,2,3,4‐tetrazines as new anti‐leukemia cancer agents
   Oznur Eyilcim et al, 2023, Chemical Biology & Drug Design CrossRef
3. CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles
   Anneloes Andriessen et al, 2022, Veterinary and Comparative Oncology CrossRef
4. Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
   Ludovica Di Martino et al, 2021, International Journal of Molecular Sciences CrossRef
5. Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
   Sonja Pavlovic et al, 2019, Genes CrossRef